Deciphering the role of <i>ELAVL1</i>: Insights from pan-cancer multiomics analyses with emphasis on nasopharyngeal carcinoma
In summary, <i>ELAVL1</i> exhibits diverse and complex involvement in tumor progression. Targeting it might inhibit tumor progression, making it a promising biomarker and therapeutic target for enhancing cancer treatment outcomes.
Authors
- Kunhao Bai (ORCID: https://orcid.org/0000-0003-1184-7576)
- Jindong Xie (ORCID: https://orcid.org/0000-0002-2482-7358)
- Wencheng Tan
- Xinpei Deng (ORCID: https://orcid.org/0000-0001-9973-2559)
- Xueqi Ou
- Jianjun Li (ORCID: https://orcid.org/0000-0003-1789-8884)
- Hailin Tang (ORCID: https://orcid.org/0000-0002-3206-782X)
- Guoxian Huang
- Kailai Li (ORCID: https://orcid.org/0000-0002-2368-3217)
- Longjun He
- Xiong Zou (ORCID: https://orcid.org/0000-0002-4524-8750)
- Jia‐Rong Wu (ORCID: https://orcid.org/0000-0003-0696-4356)
- Y Ye
- Peng Luo (ORCID: https://orcid.org/0000-0001-5800-8783)
- Yi Xie (ORCID: https://orcid.org/0000-0002-5476-1679)
- Zuyu He
Institutions
- Central South University (CN)
- Sun Yat-sen University (CN)
- Zhujiang Hospital (CN)
- Guangdong Academy of Medical Sciences (CN)
- Sun Yat-sen University Cancer Center (CN)
- Guangdong Provincial People's Hospital (CN)
- Xiangya Hospital Central South University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Journal of Translational Internal Medicine
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1515/jtim-2025-0009
- Citations
- 17
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 13.70